血清和肽素、S100B蛋白联合尿酸对儿童创伤性脑损伤预后的价值
该研究纳入86例TBI患儿,按28天预后分为存活组(51例)与死亡组(35例),按入院GCS分为中度组(9-12分,28例)与重度组(3-8分,58例),于入院第1、3、5天检测血清和肽素、S100B蛋白和尿酸。死亡组第5天三项指标均显著高于存活组,重度组第5天亦显著高于中度组(均P<0.01)。ROC分析显示第3天预测价值最高,三项联合AUC 0.940,显著高于单项(0.852、0.837、0.793)。死亡患儿第3天三项指标与GCS评分呈显著负相关。
要点
- 死亡组第5天和肽素19.37±6.50 μg/L、S100B蛋白9.52±2.86 μg/L、尿酸527.40±273.84 μmol/L,均显著高于存活组(8.06±2.14、3.75±0.97、255.38±143.75,均P<0.01)。
- 重度组第5天和肽素17.84±4.73 μg/L、S100B蛋白8.80±2.40 μg/L、尿酸494.72±262.53 μmol/L,均显著高于中度组(9.15±2.42、4.17±1.16、276.20±150.37,均P<0.01)。
- 入院后各时间点三项指标均有预测28天死亡的价值,以第3天预测价值最高;三项联合AUC 0.940,显著高于单项0.852、0.837、0.793(Z值5.392、5.704、6.612,均P<0.05)。
- 第3天联合预测灵敏度96.3%、特异度88.5%。
- 28天死亡患儿第3天和肽素、S100B蛋白、尿酸与GCS评分显著负相关(r分别为-0.862、-0.827、-0.758,均P<0.01)。
适用人群与场景
- 2017年1月1日至2019年12月31日入住儋州市人民医院的86例创伤性脑损伤患儿。
- 按入院GCS评分分为中度组(GCS 9-12分,28例)和重度组(GCS 3-8分,58例)。
- 按28天预后分为存活组(51例)和死亡组(35例)。
诊断标准与关键阈值
- 格拉斯哥昏迷评分(GCS)9-12分为中度组,3-8分为重度组。
- 28天预后分为存活组与死亡组。
研究设计与关键结果
- 研究类型为临床观察性研究,纳入86例TBI患儿,存活51例、死亡35例;中度昏迷28例、重度昏迷58例;不同预后组基线资料无显著差异。
- 死亡组入院第1天血清和肽素、S100B蛋白和尿酸水平显著高于存活组,并随住院时间延长呈升高趋势;第5天组间差异仍显著[和肽素(μg/L)19.37±6.50 vs. 8.06±2.14,S100B蛋白(μg/L)9.52±2.86 vs. 3.75±0.97,尿酸(μmol/L)527.40±273.84 vs. 255.38±143.75,均P<0.01]。
- 重度组三项指标随时间升高,且显著高于中度组[第5天和肽素(μg/L)17.84±4.73 vs. 9.15±2.42,第5天S100B蛋白(μg/L)8.80±2.40 vs. 4.17±1.16,第5天尿酸(μmol/L)494.72±262.53 vs. 276.20±150.37,均P<0.01]。
- ROC曲线分析显示入院后各时间点三项指标对28天死亡均有预测价值,第3天预测价值最高,三项联合AUC显著高于单项(AUC:0.940 vs. 0.852、0.837、0.793,Z值分别为5.392、5.704、6.612,均P<0.05),联合预测灵敏度96.3%、特异度88.5%。
- Pearson相关分析显示,28天死亡TBI患儿入院第3天血清和肽素、S100B蛋白、尿酸与GCS评分均呈显著负相关(r分别为-0.862、-0.827、-0.758,均P<0.01)。
证据类型、等级与局限
- 证据类型:临床观察性研究(非随机对照试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清和肽素、S100B蛋白、尿酸水平升高与TBI患儿病情严重程度及预后相关。
- 作者认为入院第3天联合检测三项指标对预测TBI患儿28天死亡价值更好。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the value of serum copeptin, S100B protein and uric acid (UA) levels in the prognosis of children with traumatic brain injury (TBI).
METHODS: Eighty-six children with TBI admitted to Danzhou People's Hospital from January 1st, 2017 to December 31st, 2019 were selected. The gender, age, body mass index (BMI), cause of TBI, and baseline data of body temperature, heart rate (HR) and respiratory rate (RR) were collected, and the serum copeptin, S100B protein and UA levels were recorded on the 1st, 3rd and 5th day after admission. According to 28-day prognosis, the children were divided into survival group and death group. According to the Glasgow coma score (GCS) at admission, the children were divided into moderate group (GCS score 9-12) and severe group (GCS score 3-8). The changes of serum copeptin, S100B protein and UA level of each group were observed on the 1st, 3rd and 5th day after admission. Receiver operator characteristic (ROC) curve was drawn to analyze the value of serum copeptin, S100B protein and UA in predicting the death of TBI children in 28 days. Pearson correlation method was used to analyze the correlation between GCS score and serum copeptin, S100B protein and UA in dead children during 28 days.
RESULTS: Eighty-six children were enrolled in the final analysis, 35 died and 51 survived in 28 days, with 28 in moderate coma and 58 in severe coma. There was no significant difference in the baseline data between the different prognosis groups. The serum copeptin, S100B protein and UA levels of the children in the death group on the 1st day after admission were significantly higher than those in the survival group, and showed an increasing trend with the extension of hospitalization. The differences between the death group and the survival group on the 5th day were still statistically significant [copeptin (μg/L): 19.37±6.50 vs. 8.06±2.14, S100B protein (μg/L): 9.52±2.86 vs. 3.75±0.97, UA (μmol/L): 527.40±273.84 vs. 255.38±143.75, all P < 0.01]. The levels of serum copeptin, S100B protein and UA in the severe group also increased over time, and were significantly higher than those in the moderate group [5-day copeptin (μg/L): 17.84±4.73 vs. 9.15±2.42, 5-day S100B protein (μg/L): 8.80±2.40 vs. 4.17±1.16, 5-day UA (μmol/L): 494.72±262.53 vs. 276.20±150.37, all P < 0.01]. ROC curve analysis showed that serum copeptin, S100B protein and UA at each time point after admission had predictive value for 28-day death of TBI children, and the most predictive value was on the 3rd day, and the area under ROC curve (AUC) predicted by the combination of three parameters were significantly higher than that predicted by a single one (AUC: 0.940 vs. 0.852, 0.837, 0.793, Z values were 5.392, 5.704 and 6.612, respectively, all P < 0.05), with the sensitivity and specificity of 96.3% and 88.5%, respectively. Pearson correlation analysis showed that serum copeptin, S100B protein and UA were significantly negatively correlated with GCS score on the 3rd day after admission in 28-day dead TBI children (r values were -0.862, -0.827, -0.758, respectively, all P < 0.01).
CONCLUSIONS: The increase of serum copeptin, S100B protein and UA levels is related to the severity and prognosis of TBI children. The combination of serum copeptin, S100B protein and UA on the 3rd day after admission has a better value in predicting the death of TBI children.
参考来源
- Lin L, Mai L, Chen G, et al. [Value of serum copeptin and S100B protein combined with uric acid in the prognosis of children with traumatic brain injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32576353. doi:10.3760/cma.j.cn121430-20200129-00146
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。